Skip to content

The Role of ARTificial Uterine CONtractions in Perinatal Respiratory Morbidity of Term Infants Delivered by Elective Caesarean Section

A Prospective, Randomized and Placebo Controlled Trial Comparing the Role of ARTificial Uterine CONtractions and no Intervention in Perinatal Respiratory Morbidity of Term Infants Delivered by Elective Caesarean Section - ARTCON Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03899597
Acronym
ARTCON
Enrollment
200
Registered
2019-04-02
Start date
2024-01-30
Completion date
2025-12-30
Last updated
2022-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Respiratory Distress

Brief summary

In this study, the investigators aim to investigate if artificial uterine contractions prior to elective caesarean section delivery may have an impact on the respiratory morbidity of term neonates.

Detailed description

Accumulating evidence suggests that the respiratory morbidity of infants is lower if delivered by caesarean section after the spontaneous onset of uterine contractions, or after oxytocin exposure. Moreover, benefits for the mother due to stretching of the lower uterine segment and possible lower blood loss are plausible. In obstetrics, there is a well described and standardized way to induce artificial uterine contractions in order to predict fetal wellbeing and tolerance of labor, without inducing the labor itself. This is the oxytocin challenge test (OCT). Although the OCT has not been performed previously in the context of planned elective caesarean section deliveries, it is generally considered a safe procedure if appropriate monitoring is granted. Hence evaluation of the role of artificial uterine contractions in perinatal respiratory morbidity of term infants delivered by elective caesarean section is possible and of interest.

Interventions

DRUGOxytocin

The intervention group (ARTCON) will receive the standard assignment for the elective caesarean section, but at least one hour before surgery oxytocin exposure will be performed with cardiotocographic (CTG) monitoring and obstetrical supervision.

OTHERNormal saline

The control group (SA) will receive the standard assignment for the elective caesarean section, but at least one hour before surgery placebo exposure will be performed with cardiotocographic (CTG) monitoring and obstetrical supervision.

Sponsors

Institute for the Care of Mother and Child, Prague, Czech Republic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Term/near-term pregnancy (36+0 - 41+6 weeks of gestation) * Planned delivery by elective caesarean section * Absence of any

Exclusion criteria

* Informed consent obtained

Design outcomes

Primary

MeasureTime frameDescription
Incidence of neonatal respiratory morbidityFirst 24 hours after deliveryNeonatal respiratory morbidity during the first 24 hours after delivery is defined as presence of transitory tachypnoea of the newborn, or respiratory distress syndrome, and/or persistent pulmonary hypertension of the newborn.

Secondary

MeasureTime frameDescription
Oxytocin challenge test safety and feasibilityBefore elective caesarean sectionCTG trace suggestive of hypoxia during oxytocin exposure. Subjectively unbearable pain and discomfort during oxytocin exposure.
Maternal blood lossDuring caesarean sectionDefined as the difference in hemoglobin levels before and after surgery
Total duration of surgeryTime of caesarean sectionMinutes
Lamellar body count in amniotic fluidDuring caesarean sectionParticles per microlitre
Incidence of transitory tachypnoea of the newbornFirst 24 hours after deliveryBreathing rate above 60 per minute at least for 3 hours (3 consecutive measurements) and /or dyspnoea for at least two hours in the follow-up period (consecutive) and /or the need for oxygen therapy during the first 24 hours after birth.
Oxytocin challenge test effectivityBefore elective caesarean sectionContractions being induced (felt or CTG recorded) before elective caesarean section
Incidence of perinatal hypoxiaFirst 24 hours after deliveryPresence of diagnostic criteria of hypoxic-ischaemic encephalopathy: 5-min Apgar score of less than 5, need for delivery room intubation or CPR, umbilical cord arterial pH less than 7.00 and abnormal neurological signs such as hypotonic muscles or lack of sucking reflex
Incidence of early onset sepsisFirst 48 hours after deliveryClinical or proven (positive blood culture)
Incidence of significantly increased neonatal pulmonary vascular resistanceFirst 72 hours after deliveryPulmonary vascular resistance measurements consist of measuring the right ventricular systolic pressure (RVSP), pulmonary artery pressure (PAP) and persistent ductus arteriosus (PDA) shunting (if present).
Incidence of persistent pulmonary hypertension of the newbornFirst 24 hours after deliveryDefined by marked pulmonary hypertension that causes hypoxemia secondary to right-to-left shunting of blood at the foramen ovale and ductus arteriosus.
Incidence of respiratory distress syndromeFirst 24 hours after deliveryDefined by need for ventilatory support in the first 24 hours after birth (nasal continuous positive airway pressure, mechanical ventilation) and X-ray examination results consistent with RDS diagnosis.

Countries

Czechia

Contacts

Primary ContactIvan Berka, MD
ivan.berka@upmd.eu0042296511807
Backup ContactZbynek Stranak, MD
zbynek.stranak@upmd.eu0042296511806

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026